HRP20090211T1 - Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation - Google Patents

Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation

Info

Publication number
HRP20090211T1
HRP20090211T1 HR20090211T HRP20090211T HRP20090211T1 HR P20090211 T1 HRP20090211 T1 HR P20090211T1 HR 20090211 T HR20090211 T HR 20090211T HR P20090211 T HRP20090211 T HR P20090211T HR P20090211 T1 HRP20090211 T1 HR P20090211T1
Authority
HR
Croatia
Prior art keywords
omeprazole
magnesium salt
processes
preparation
solid forms
Prior art date
Application number
HR20090211T
Other languages
English (en)
Croatian (hr)
Inventor
Berenguer Maimo Ramon
Coppi Laura
Gasanz Guill�n Yolanda
Medrano Rup�rez Jorge
Original Assignee
Esteve Quimica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica filed Critical Esteve Quimica
Publication of HRP20090211T1 publication Critical patent/HRP20090211T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20090211T 2004-07-02 2005-06-29 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation HRP20090211T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401729A ES2246149B1 (es) 2004-07-02 2004-07-02 Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
PCT/EP2005/053062 WO2006003163A1 (en) 2004-07-02 2005-06-29 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation

Publications (1)

Publication Number Publication Date
HRP20090211T1 true HRP20090211T1 (en) 2009-05-31

Family

ID=34972307

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090211T HRP20090211T1 (en) 2004-07-02 2005-06-29 Solid forms of the magnesium salt of (s)-omeprazole and processes for their preparation

Country Status (19)

Country Link
US (1) US7902370B2 (forum.php)
EP (1) EP1765807B1 (forum.php)
JP (2) JP5575366B2 (forum.php)
KR (1) KR101290035B1 (forum.php)
CN (1) CN1976923B (forum.php)
AT (1) ATE425975T1 (forum.php)
AU (1) AU2005259205B2 (forum.php)
CA (1) CA2570559C (forum.php)
CY (1) CY1109048T1 (forum.php)
DE (1) DE602005013382D1 (forum.php)
DK (1) DK1765807T3 (forum.php)
ES (2) ES2246149B1 (forum.php)
HR (1) HRP20090211T1 (forum.php)
MX (1) MXPA06014736A (forum.php)
NO (1) NO20070635L (forum.php)
NZ (1) NZ552458A (forum.php)
PT (1) PT1765807E (forum.php)
WO (1) WO2006003163A1 (forum.php)
ZA (1) ZA200700865B (forum.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2147918A1 (en) * 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
CN103044400A (zh) * 2012-12-21 2013-04-17 北京华禧联合科技发展有限公司 埃索美拉唑镁盐及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
ATE414509T1 (de) * 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
CN1183127C (zh) * 1999-08-26 2005-01-05 艾伊法马公司 烷氧基取代的苯并咪唑化合物,含有它们的药物制剂及使用它们的方法
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) * 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
CA2409258A1 (en) * 2000-05-15 2001-11-22 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
EP1306375B1 (en) * 2000-08-04 2006-10-11 Takeda Pharmaceutical Company Limited Salts of benzimidazole compound and application thereof
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
SI20875A (sl) * 2001-04-25 2002-10-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristalna oblika omeprazola
WO2003089408A2 (en) * 2002-04-22 2003-10-30 Sun Pharmaceutical Industries Limited Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
WO2004020436A1 (en) 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
AU2003278406A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Amorphous form of esomeprazole salts
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
WO2004089935A1 (en) * 2003-04-10 2004-10-21 Hetero Drugs Limitd Novel crystalline forms of s-omeprazole magnesium
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.

Also Published As

Publication number Publication date
CN1976923B (zh) 2011-08-24
ATE425975T1 (de) 2009-04-15
NZ552458A (en) 2010-07-30
US20070249684A1 (en) 2007-10-25
ES2246149B1 (es) 2007-06-01
KR101290035B1 (ko) 2013-07-30
DE602005013382D1 (de) 2009-04-30
JP2008505160A (ja) 2008-02-21
WO2006003163A1 (en) 2006-01-12
CN1976923A (zh) 2007-06-06
KR20070031992A (ko) 2007-03-20
CY1109048T1 (forum.php) 2014-07-02
EP1765807A1 (en) 2007-03-28
PT1765807E (pt) 2009-04-13
US7902370B2 (en) 2011-03-08
AU2005259205A1 (en) 2006-01-12
JP2014169302A (ja) 2014-09-18
ZA200700865B (en) 2009-09-30
DK1765807T3 (da) 2009-06-08
JP5575366B2 (ja) 2014-08-20
AU2005259205B2 (en) 2011-01-27
ES2323319T3 (es) 2009-07-13
CA2570559C (en) 2012-08-28
EP1765807B1 (en) 2009-03-18
CA2570559A1 (en) 2006-01-12
MXPA06014736A (es) 2007-06-25
ES2246149A1 (es) 2006-02-01
NO20070635L (no) 2007-03-20

Similar Documents

Publication Publication Date Title
IL182061A0 (en) Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
TWI369580B (en) Photosensitive composition, compound for use in the photosensitive composition and pattern forming method using the photosensitive composition
NO20081016L (no) Nye 1-aryl-3-azabicyklo(3.1.0)heksaner, fremstilling og bruk for å behandle nevropsykiatriske lidelser
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
IS8418A (is) 1,4-tvíútskiptar ísókínílónafleiður sem RAF-kínasatálmar sem eru gagnlegar til að meðhöndla fjölgunarsjúkdóma
TWI369351B (en) 2,4-diamino-pyrimidines as aurora inhibitors
EP1945159A4 (en) MAGNETIC NANO-SCALE PARTICLE COMPOSITIONS AND ASSOCIATED THERAPEUTIC METHODS
EP2177224A3 (en) Agents for preventing and treating disorders involving modulation of the RyR receptors
MX2009001327A (es) Compuestos de indol.
UY27712A1 (es) Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización
ZA200801441B (en) p38MAP kinase inhibitors and methods for using the same
EP1612604A3 (en) Compositions and processes for immersion lithography
SI1761266T1 (sl) Spojine, formulacije in postopki za zdravljenje ali preprečevanje vnetnih kožnih motenj
IL176420A0 (en) Process for the manufacture of 2,3-dichloropyridine
PT2383271E (pt) Aminoquinolonas como inibidores de gsk-3
NO20075275L (no) Nye forbindelser
SI2803366T1 (sl) Sestavki za zdravljenje ali preprečevanje z oksalatom-povezane bolezni
EP2177506A4 (en) POSITIVE RESIST COMPOSITION, PATTERN FORMATION METHOD USING THE COMPOSITION, AND COMPOUND USED IN THE COMPOSITION
WO2007095161A3 (en) Methods and compositions for treating disorders associated with increased bone turnover and osteopenia
TWI318724B (en) Method for forming positive resist composition, positive resist composition, and method for forming resist pattern
IL178261A0 (en) Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
WO2002089736A3 (en) Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
RS52944B (en) ROFLUMILAST FOR TREATMENT OF PULMONARY HYPERTENSION
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
WO2004041215A3 (en) Methods for treating gastroesophageal reflux disease